·
Septicaemia.
·
Infections of ear, nose, throat.
·
Lung and bronchi.
·
Endocarditis.
·
Meningitis.
·
Infections of the intestines.
·
Infections of the urinary tract.
·
Genital tract infections.
·
Mycobacterial infections.
Septicaemia
|
Bacterial pathogen |
Antibacterial therapy |
|
Septicaemia follows gastrointestinal or genital
tract surgery: ·
Escherichia coli ·
Bacteroides. ·
Streptococci. ·
Enterococci. |
·
Cefuroxime + metronidazole or ·
Gentamicin + amoxycillin + metronidazole |
|
Septicaemia related to urinary tract infection: ·
Escherichia coli ·
Enterococci ·
Pseudomonas aeruginosa |
·
Gentamicin + amoxycillin or ·
Gentamicin + ceftazidime (where pseudonomas
aeruginosa is suspected). |
|
Neonatal septicaemia: ·
Streptococci ·
Coliforms ·
Pseudomonas aeruginosa |
·
Cefotaxime alone or with netilmicin. |
|
Abscess: staphylococcus septicaemia |
·
Flucloxacillin. |
|
Toxic shock syndrome |
·
Flucloxacillin. |
Ear, nose and throat
|
Bacterial pathogen |
Antibacterial therapy |
|
Sinusitis: ·
Streptococcus pneumoniae ·
Streptococcus pyogenes ·
Haemophilus influenzae ·
Moraxella catarrhalis |
·
Oral amoxycillin or ·
Oral doxycycline. |
|
Otitis media: ·
Streptococcus pneumoniae ·
Haemophilus influenzae ·
Moraxella catarrhalis ·
Streptococcus pyogenes ·
Staphylococcus aureus |
·
Amoxycillin |
|
Pharyngitis: ·
Streptococcus pyogenes ·
Secondary invaders: streptococcus pneumoniae &
Haemophilus influenzae |
·
Benzylpenicillin ·
Chemoprophylaxis of streptococcal (Group A)
infection: Penicillin V |
|
Vincent’s infection |
·
Benzylpenicillin |
|
Diphtheria |
·
Antitoxin ·
Erythromycin or benzylpenicillin |
|
Whooping cough |
·
Erythromycin |
Lungs and Bronchi
|
Bacterial pathogen |
Antibacterial therapy |
|
Bronchitis: ·
Streptococcus pneumoniae ·
Haemophilus influenzae |
·
Amoxycillin or ·
Trimethoprim |
|
Segmental or lobar pneumonia: ·
Streptococcus pneumoniae ·
Haemophilus influenzae |
·
Benzylpenicillin i.v. or ·
Amoxycillin or ·
Erythromycin |
|
Pneumonia following influenza: ·
Staphylococcus aureus |
·
Sodium fusidate + flucloxacillin i.v. |
|
Atypical pneumonia: ·
Mycoplasma pneumoniae ·
Chlamydia psittaci ·
Coxiella burnetii |
·
Tetracycline oral |
|
Nosocomial pneumonia: ·
Staphylococcus aureus ·
Streptococcus pneumoniae ·
Pseudomonas aeruginosa ·
Enterobacteriaceae ·
Haemophilus influenzae |
·
Initiate ciprofloxacin or ceftazidime until
results of sputum culture and bacterial sensitivity are known. |
|
Pneumonia in people with chronic lung disease: ·
Streptococcus pneumoniae ·
Haemophilus influenazae ·
Klebsiella pneumoniae ·
Moraxella catarrhalis |
·
Streptococcus & haemophilus: amoxycillin or
trimethoprim or co-amoxiclav or a quinolone. ·
Klebsiella: cefotaxime + an aminoglycoside. ·
Moraxella: co-amoxiclav or erythromycin. |
|
Pneumonia in immunocompromised: ·
Enterobacteriaceae ·
Klebsiella spp ·
Pneumocystis carinii |
·
Aminoglycoside + amoxycillin until the pathogen is
known. ·
Aerobic Gram-negative bacilli: cefotaxime or
ceftazidime ·
Pneumocystis: co-trimoxazole |
|
Legionnaire’s disease |
·
Erythromycin |
|
Pneumonia due to anaerobic microorganisms: ·
Anaerobic streptococci ·
Bacteroides spp ·
Fusobacterium |
·
Cefuroxime + metronidazole |
Endocarditis
1.
Common pathogens:
a.
Streptococci and staphylococci are causal in 80% of cases with viridans
group streptococci, the most common pathogen.
b. In
intravenous drug abusers, Staphylococcus aureus is the most likely organism.
c. For
culture-negative endocarditis, it is best regarded as being due to streptococci
and treated accordingly.
2.
Principles of Treatment:
a. High
doses of bactericidal drugs are needed because the organisms are difficult to
access in avascular vegetations on valves.
b.
Drugs should be given parenterally initially and by intravenous bolus
injection which achieve the high peak concentrations needed to penetrate the
avascular vegetations.
c. The
infusion site should be changed every 2 – 3 days to prevent opportunistic
infection, which is usually with staphylococci or fungi.
d.
Prolonged therapy is needed, usually 4 weeks, and in the case of infected
prosthetic valves at least 6 weeks.
3.
Drugs used:
|
Bacterial pathogen |
Antibacterial therapy |
|
Initial treatment |
·
Benzylpenicillin + gentamicin ·
Flucloxacillin + gentamin or sodium fusidate (if
staphylococcus aureus is suspected. |
|
Viridans group streptococci |
·
Benzylpenicillin + gentamicin |
|
Enterococcus faecalis |
·
Benzylpenicllin + gentamicin |
|
Staphylococcus aureus |
·
Flucloxacillin + gentamicin i.v. or sodium
fusidate oral |
|
Staphylococcus epidermidis |
·
Flucloxacillin + gentamicin i.v. or sodium
fusidate oral |
|
Coxiella or chlamydiae |
·
Tetracycline oral |
|
Fungal endocarditis |
·
Amphotericin + flucytosine |
|
Culture-negative endocarditis |
·
Benzylpenicillin + gentamicin i.v. for 6 weeks. |
4.
Prophylaxis:
a.
Transient bacteraemia can be provoked by dental procedures, surgical
incision of the skin, instrumentation of the urinary tract and parturition.
b.
People with acquired or congenital heart defects are at risk of
bacteraemia and are protected by antimicrobials prophylactically.
c. The
drugs are given as a short course in high dose at the time of the procedure to
coincide with the bacteraemia and avoid emergence of resistant organisms.
5.
Drugs used for Prophylaxis:
|
Procedure |
Antibacterial therapy |
|
Dental procedures |
·
Amoxycillin oral 1h before the procedure. ·
Clindamycin oral 1h before the procedure. |
|
Under general anaesthesia |
·
Amoxycillin oral and / or with probenecid. |
|
Prosthetic valves / previous endocarditis |
·
Amoxycillin i.m or i.v. + gentamicin for induction
then amoxycillin oral later. ·
Vancomycin i.v. then gentamicin i.v. or
clindamycin over 10min at induction. |
Meningitis
1.
Principles of Treatment:
a.
Speed of initiating treatment and accurate bacteriological diagnosis are
the major factors determining the fate of the patient.
b.
When meningococcal disease is suspected, treatment with benzylpenicillin
should be started before transfer to hospital.
c.
Drugs must be given i.v.
2.
Common pathogens:
a.
Children and adults: Neisseria meningitidis, Streptococcus pneumoniae,
Haemophilus influenzae.
b.
Neonates: Escherichia coli, Group B streptococci, Listeria monocytogenes.
3.
Drugs used in treatment and prophylaxis:
|
Bacterial pathogen |
Antibacterial therapy |
|
Neisseria meningitidis |
·
Benzylpenicillin or ·
Cefotaxime ·
Hydrocortisone: if there is evidence of
adrenocortical insufficiency. ·
Prophylaxis: rifampicin or minocycline. |
|
Streptococcus pneumoniae |
·
Cefotaxime or ·
Benzylpenicillin |
|
Haemophilus influenzae |
·
Chloramphenicol or ·
Cefotaxime ·
Prophylaxis: rifampicin |
|
Escherichia coli or Group B streptococci |
·
Cefotaxime or ·
Ceftazidime |
|
Listeria monocytogenes |
·
Ampicillin |
Infecations of the intestines
1.
Principles of Treatment:
a.
Antimicrobial therapy should be reserved for specific conditions with
identified pathogens where benefit has been shown.
b.
Maintenance of water and electrolyte balance, either by i.v. infusion or
orally with a glucose-electrolyte solution together with an antimotility drug
are the mainstay of therapy is such cases.
2.
Drugs used:
|
Bacterial pathogen |
Antibacterial therapy |
|
Campylobacter jejuni |
·
Erythromycin or ·
Ciprofloxacin oral |
|
Shigella |
·
Ciprofloxacin or ·
Amoxycillin oral |
|
Salmonella |
·
Ciprofloxacin or ·
Amoxycillin or ·
Co-trimoxazole |
|
Typhoid fever |
·
Ciprofloxacin or ·
Amoxycillin or ·
Co-trimoxazole |
|
Escherichia coli |
·
Ciprofloxacin |
|
Staphylococcus enteritis |
·
Vancomycin oral or ·
Flucloxacillin oral or i.v. |
|
Vibrio cholerae |
·
Doxycycline |
|
Peritonitis: coliforms, anaerobes &
streptococci |
·
Gentamicin, amoxycillin + metronidazole or ·
Cefuroxime + metronidazole |
Infection of the urinary tract
1.
Common pathogens:
a.
Escherichia coli.
b.
Proteus spp.
c.
Klebsiella pneumoniae.
d.
Pseudomonas aeruginosa.
e.
Enterobacteriaceae.
f.
Staphylococcus saprophyticus.
2.
Principles of Treatment:
a.
Identification of the causative organisms and of the sensitivity to drugs
are important because of the range of organisms and the prevalence of resistant
strains.
b. For
infection of the lower urinary tract a low dose may be effective, as many
antimicrobials are concentrated in the urine.
c.
Infections of the substance of the kidney requires the doses needed for
any systemic infection.
d.
Elimination of infection is hastened by a large urine volume and by
frequent micturition.
3. Drug
treatment of urinary tract infections:
|
Category |
Antibacterial therapy |
|
Lower urinary tract infection |
·
Oral cephalosporin: cephalexin or ·
Trimethoprim or ·
Ampicillin |
|
Upper urinary tract infection |
·
Gentamicin + amoxycillin i.v. or ·
Cefotaxime i.v. |
|
Recurrent urinary tract infection |
·
Trimethoprim |
|
Asymptomatic infection |
·
Amoxycillin or a ·
Cephalosporin |
|
Prostatitis |
·
Trimethoprim or ·
Ciprofloxacin or ·
Erythromycin |
|
Chemoprophylaxis |
·
Nitrofurantoin ·
Nalidixic acid ·
Trimethoprim |
4.
Nitrofurantoin:
a. Half-life:
30min.
b. A
synthetic antimicrobial active against the majority of urinary pathogens except
pseudomonads.
c. It
is well absorbed from the GI tract and is concentrated in the urine.
d. Main
use is now for prophylaxis.
e.
Adverse effects: nausea and vomiting, diarrhea, polyneuritis in patients
with renal impairment.
5.
Fosfomycin:
a.
Inhibit cell wall synthesis.
b.
Rapidly bactericidal.
c.
Active against a broad spectrum of bacteria isolated in urinary tract
infections: Escherichia coli, Proteus spp, Klebsiella pneumoniae, Staphylococci
and Streptococci.
d. Used
to treat uncomplicated urinary tract infections.
Genital tract infections
|
Bacterial pathogen |
Antibacterial therapy |
|
Anogenital gonorrhoea |
·
Amoxycillin + probenecid oral. ·
Spectinomycin i.v. or ·
Ciprofloxacin oral ·
Tetracycline: with co-existent chlamydiae
infection |
|
Pharyngeal gonorrhoea |
·
Tetracycline |
|
Nongonococcal urethritis: ·
Chlamydia trachomatis ·
Ureaplasma urealyticum |
·
Tetracycline or ·
Erythromycin oral |
|
Pelvic inflammatory disease: ·
Chlamydiae trachomatis ·
Neisseria gonorrhoea ·
Mycoplasma hominis |
·
Metronidazole + doxycycline oral |
|
Syphilis |
·
Benzylpenicillin ·
Tetracycline or ·
Erythromycin |
|
Chancroid: Haemophilus ducreyi |
·
Erythromycin or ·
Ceftriaxone or ·
Azithromycin |
|
Granuloma inguinale |
·
Ampicillin or ·
Co-trimoxazole or ·
Tetracycline |
|
Anaerobic vaginosis: ·
Trichomonas vaginalis ·
Candida albicans ·
Gardnreella vaginalis ·
Bacteroids spp |
·
Metronidazole oral |
Eye infections
|
Bacterial pathogen |
Antibacterial therapy |
|
Superficial infection: |
·
Chloramphenicol ·
Gentamicin ·
Ciprofloxacin ·
Neomycin ·
Tobramycin |
|
Chlamydial conjunctivitis |
·
Tetracycline |
Mycobacterial infections
1.
Principles of Therapy:
a. A
large number of actively multiplying bacilli must be killed: isoniazid achieves
this.
b.
Treat persisters, i.e. semidormant bacilli that metabolize slowly or
intermittently: rifampicin and pyrazinamide are the most efficacious.
c.
Prevent the emergence of drug resistance by multiple therapy to suppress
drug-resistant mutants that exist in all large bacterial populations: isoniazid
and rifampicin are best.
d.
Combined formulations are used to ensure that poor compliance does not
result in monotherapy with consequent drug resistance.
2.
Treatment Regimens:
a. An
unsupervised regiment of daily dosing comprising isoniazid and rifampicin for 6
months, plus pyrazinamide for the first 2 months.
b. A
supervised (directly observed) regimen comprising thrice-weekly dosing with
isoniazid and rifampicin for 6 months, plus pyrazinamide for the first 2 months.
c. With
both above regimens, ethambutol by mouth or streptomycin i.m. should be added
for the first 2 months.
d. A
less costly, yet effective regimen: supervised daily administration of
isoniazid, rifampicin, pyrazinamide and either ethambutol or streptomycin for 2
months followed by 6 months of unsupervised daily isoniazid and thiacetazone.
3.
Chemoprophylaxis:
a.
Treatment of infected by symptom-free individuals.
b.
Justified in children under age of 3 because they have a high risk of
disseminated disease.
c.
Isoniazid used alone for 6 months may be used since there is little risk
of resistant organisms emerging.
4.
Pregnancy: drug treatment should never be interrupted or postponed
during pregnancy.
5.
Meningeal tuberculosis: use isoniazid and pyrazinamide which penetrate
well into the CSF.
6.
Leprosy:
a.
Paucibacillary disease: dapsone and rifampicin for 6 months.
b.
Multibacillary disease: dapsone, rifampicin and clofazimine for 2 years.
Other bacterial infections
1.
Burns: sliver sulphadiazine cream.
2. Gas
gangrene: prevented by benzylpenicillin.
3.
Wounds:
a.
Systemic chemoprophylaxis is necessary for several days at least in dirty
wounds.
b.
Benzylpenicillin is probably the best, but in the case of penetrating
abdominal wounds, metronidazole should be added.